These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 6830015)

  • 21. Serologic and protective characterization of Moraxella bovis pili.
    Lehr C; Jayappa HG; Goodnow RA
    Cornell Vet; 1985 Oct; 75(4):484-92. PubMed ID: 2865080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of two commercial infectious bovine keratoconjunctivitis vaccines.
    Smith PC; Blankenship T; Hoover TR; Powe T; Wright JC
    Am J Vet Res; 1990 Jul; 51(7):1147-50. PubMed ID: 2389894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of vaccination and treatment in controlling naturally occurring infectious bovine keratoconjunctivitis.
    Hughes DE; Kohlmeier RH; Pugh GW; Booth GD
    Am J Vet Res; 1979 Feb; 40(2):241-4. PubMed ID: 464360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized controlled field trial to assess efficacy of a Moraxella bovis pilin-cytotoxin-Moraxella bovoculi cytotoxin subunit vaccine to prevent naturally occurring infectious bovine keratoconjunctivitis.
    Angelos JA; Gohary KG; Ball LM; Hess JF
    Am J Vet Res; 2012 Oct; 73(10):1670-5. PubMed ID: 23013196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of acute ocular Moraxella bovis infections in calves with a parenterally administered long-acting oxytetracycline formulation.
    Smith JA; George LW
    Am J Vet Res; 1985 Apr; 46(4):804-7. PubMed ID: 4014830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serologic response of vaccinated cattle to strains of Moraxella bovis isolated during epizootics of keratoconjunctivitis.
    Pugh GW; Hughes DE; Booth GD
    Am J Vet Res; 1978 Jan; 39(1):55-7. PubMed ID: 415645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of Moraxella bovis antibodies in the SIgA, IgG, and IgM classes of immunoglobulin in bovine lacrimal secretions by an indirect fluorescent antibody test.
    Killinger AH; Weisiger RM; Helper LC; Mansfield ME
    Am J Vet Res; 1978 Jun; 39(6):931-4. PubMed ID: 352205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors related to the prevalence of infectious bovine keratoconjunctivitis.
    Webber JJ; Selby LA
    J Am Vet Med Assoc; 1981 Oct; 179(8):823-6. PubMed ID: 6281222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infectious bovine keratoconjunctivitis: influence of age on development of disease in vaccinated and nonvaccinated calves after exposure to Moraxella bovis.
    Pugh GW; McDonald TJ; Booth GD
    Am J Vet Res; 1979 Jun; 40(6):762-6. PubMed ID: 475126
    [No Abstract]   [Full Text] [Related]  

  • 30. Experimentally induced infectious bovine keratoconjunctivitis: potentiation of a Moraxella bovis pilus vaccine's immunogenicity by vaccination with Mycobacterium paratuberculosis bacterin.
    Pugh GW; McDonald TJ; Larsen AB
    Am J Vet Res; 1978 Oct; 39(10):1656-61. PubMed ID: 717879
    [No Abstract]   [Full Text] [Related]  

  • 31. Infectious bovine keratoconjunctivitis II. Antibodies in lacrimal secretions of cattle naturally or experimentally infected with Moraxella bovis.
    Nayar PS; Saunders JR
    Can J Comp Med; 1975 Jan; 39(1):32-40. PubMed ID: 803398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infectious bovine keratoconjunctivitis: evidence for genetic modulation of resistance in purebred Hereford cattle.
    Pugh GW; McDonald TJ; Kopecky KE; Kvasnicka WG
    Am J Vet Res; 1986 Apr; 47(4):885-9. PubMed ID: 3516033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induced infectious bovine keratoconjunctivitis: vaccination with whole cell bacterins of Moraxella bovis mixed with Freund's incomplete adjuvant.
    Hughes DE; Pugh GW; Booth GD
    Am J Vet Res; 1977 Nov; 38(11):1905-7. PubMed ID: 931173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infectious bovine keratoconjunctivitis: bacteriologic, immunologic, and clinical responses of cattle to experimental exposure with Moraxella bovis.
    Weech GM; Renshaw HW
    Comp Immunol Microbiol Infect Dis; 1983; 6(1):81-94. PubMed ID: 6825419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infectious bovine keratoconjunctivitis I. Experimental production.
    Nayar PS; Saunders JR
    Can J Comp Med; 1975 Jan; 39(1):22-31. PubMed ID: 163126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of tulathromycin for treatment of cattle with acute ocular Moraxella bovis infections.
    Lane VM; George LW; Cleaver DM
    J Am Vet Med Assoc; 2006 Aug; 229(4):557-61. PubMed ID: 16910856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of infectious bovine keratoconjunctivitis by modified-live infectious bovine rhinotracheitis virus vaccine.
    George LW; Ardans A; Mihalyi J; Guerra MR
    Am J Vet Res; 1988 Nov; 49(11):1800-6. PubMed ID: 2854704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of naturally occurring infectious bovine keratoconjunctivitis with a recombinant Moraxella bovis cytotoxin-ISCOM matrix adjuvanted vaccine.
    Angelos JA; Hess JF; George LW
    Vaccine; 2004 Dec; 23(4):537-45. PubMed ID: 15530703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in titres of Moraxella bovis-specific IgG in growing cattle.
    Maidment DC; Batty DL
    Br Vet J; 1986; 142(1):65-9. PubMed ID: 3947934
    [No Abstract]   [Full Text] [Related]  

  • 40. Experimentally induced infectious bovine keratoconjunctivitis: vaccination with nonviable Moraxella bovis culture.
    Hughes DE; Pugh GW
    Am J Vet Res; 1972 Dec; 33(12):2475-9. PubMed ID: 4641206
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.